AssayIndex
Reports by quarter

Reports submitted in 2025-Q4 · page 19

Provenance classification became a required field. Median purity for the quarter is 99.12 % area, n=762. Read the 2025-Q4 state-of-the-index report →

762 records20 pagesmedian on this page 99.16 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019281SemaglutideAMBAMB-2510-H5619Janoshik2025-Q498.896.2588.6Buyer-sourced2MARGINAL
AX-2025-018983Enclomiphene citrateASYASY-{CAT}-1806Janoshik2025-Q499.733.20102.3Buyer-sourced1FAIL
AX-2025-018627GHRP-6QSCQSC-2508-F5504Janoshik2025-Q499.584.42103.1Buyer-sourced0PASS
AX-2025-018485CJC-1295 with DACWWBWWB-2509-J2816PeptideMeter2025-Q499.023.40—Buyer-sourced0PASS
AX-2025-021074AOD-9604BCHBCH-2509-K4227Janoshik2025-Q498.274.65105.1Buyer-sourced0PASS
AX-2025-020388SemaglutideMKMMKM-2507-D4229Janoshik2025-Q499.045.3194.9Buyer-sourced0PASS
AX-2025-020318Enclomiphene citrateGGPepsGGPE-2510-H2976PeptideMeter2025-Q499.935.12102.4Buyer-sourced0FAIL
AX-2025-020274SemaxGGPepsGGPE-2510-C1819Janoshik2025-Q498.957.79—Buyer-sourced0PASS
AX-2025-020265CJC-1295 (no DAC)GGPepsGGPE-2507-D1397Janoshik2025-Q498.784.05—Buyer-sourced0PASS
AX-2025-020135TB-500ERPERP-2511-L9306Kestrel2025-Q499.935.41—Supplier-supplied1MARGINAL
AX-2025-019855SemaglutideHomopeptideHOMO-2509-F5826Nordanalyt2025-Q499.574.90—Buyer-sourced0PASS
AX-2025-020544PEG-MGFSSASSA-2505-U7007Nordanalyt2025-Q496.042.6989.2Buyer-sourced2MARGINAL
AX-2025-020023SemaglutideSWBSWB-2511-B7324Kestrel2025-Q498.805.5594.7Laboratory-retained0PASS
AX-2025-019451N-Acetyl Semax AmideJEEPJEEP-2507-U8215Medutest2025-Q499.848.2298.8Buyer-sourced1FAIL
AX-2025-019858SemaglutideHomopeptideHOMO-2509-F5826Janoshik2025-Q499.364.8489.6Buyer-sourced1MARGINAL
AX-2025-019355SemaglutideHYBHYB-2510-H6122VendorInvestigate2025-Q498.904.9091.2Buyer-sourced0PASS
AX-2025-018894Kisspeptin-10TFSTFS-{CAT}-9204PeptideMeter2025-Q499.104.03100.8Buyer-sourced0PASS
AX-2025-021201Enclomiphene citratePPGPPG-2509-M6879Janoshik2025-Q499.566.8295.9Buyer-sourced0FAIL
AX-2025-021094SemaglutideBCHBCH-2505-Y5388Nordanalyt2025-Q498.146.41—Buyer-sourced1MARGINAL
AX-2025-020334DesmopressinGGPepsGGPE-2511-Y3312Janoshik2025-Q499.443.03—Buyer-sourced0PASS
AX-2025-019282SemaglutideAMBAMB-2510-H5619Janoshik2025-Q498.826.80—Buyer-sourced1MARGINAL
AX-2025-019136LiraglutideGSPGSP-2506-P4163Janoshik2025-Q499.102.55—Buyer-sourced0PASS
AX-2025-018536GHRP-2QYBQYB-2510-D4215Janoshik2025-Q499.344.10—Buyer-sourced0PASS
AX-2025-021054GonadorelinBCHBCH-2510-F4167Janoshik2025-Q498.695.65102.6Buyer-sourced0PASS
AX-2025-021053GonadorelinBCHBCH-2510-F4167Janoshik2025-Q499.185.3294.3Supplier-supplied0PASS
AX-2025-019795MK-677 (Ibutamoren mesylate)HomopeptideHOMO-2506-L4686PeptideMeter2025-Q499.931.31103.3Buyer-sourced0FAIL
AX-2025-021086CagrilintideBCHBCH-2509-A4594Janoshik2025-Q499.496.30—Buyer-sourced1MARGINAL
AX-2025-020269MGFGGPepsGGPE-2506-T1988Medutest2025-Q498.704.2096.4Supplier-supplied1FAIL
AX-2025-018449Melanotan IIWWBWWB-2510-P2932Janoshik2025-Q499.545.14—Buyer-sourced0PASS
AX-2025-0203555-Amino-1MQMKMMKM-2506-T3988Medutest2025-Q499.266.41100.6Buyer-sourced0FAIL
AX-2025-019487SS-31 (Elamipretide)JEEPJEEP-2511-B8241Janoshik2025-Q499.684.8389.6Buyer-sourced2MARGINAL
AX-2025-018537GHRP-2QYBQYB-2510-D4215Janoshik2025-Q498.784.25—Buyer-sourced0FAIL
AX-2025-020273SemaxGGPepsGGPE-2510-C1819VendorInvestigate2025-Q499.147.78—Buyer-sourced0PASS
AX-2025-019361Enclomiphene citrateHYBHYB-2510-J6404Janoshik2025-Q499.035.2092.1Buyer-sourced0FAIL
AX-2025-019032BPC-157ASYASY-{CAT}-2128VendorInvestigate2025-Q499.934.98106.0Buyer-sourced0PASS
AX-2025-018689TirzepatideQSCQSC-2511-S6768Janoshik2025-Q499.424.7688.5Buyer-sourced2MARGINAL
AX-2025-020317Enclomiphene citrateGGPepsGGPE-2510-H2976PeptideMeter2025-Q499.935.9289.4Buyer-sourced1FAIL
AX-2025-019553SelankTFCTFC-2505-A9766Janoshik2025-Q499.057.94—Buyer-sourced0PASS
AX-2025-020589IGF-1 DES (1-3)SSASSA-2509-Y7224Janoshik2025-Q498.076.48—Buyer-sourced0PASS
AX-2025-019679SemaxTFCTFC-2505-H2637Janoshik2025-Q499.747.67—Buyer-sourced0PASS